Zobrazeno 1 - 10
of 102
pro vyhledávání: '"M M Van den Heuvel-Eibrink"'
Autor:
I M A A van Roessel, J E Gorter, B Bakker, M M van den Heuvel-Eibrink, M H Lequin, J van der Lugt, L Meijer, A Y N Schouten-van Meeteren, H M van Santen
Publikováno v:
Endocrine Connections, Vol 13, Iss 10, Pp 1-9 (2024)
Objective: Children with a supratentorial midline low-grade glioma (LGG) may be at risk for impaired bone health due to hypothalamic-pituitary dysfunction, obesity, exposure to multiple treatment modalities, and/or decreased mobility. The presence of
Externí odkaz:
https://doaj.org/article/7ed742e2aa934db7a99ef62ed41a9caf
Autor:
V G Pluimakers, M van Waas, C W N Looman, M P de Maat, R de Jonge, P Delhanty, M Huisman, F U S Mattace-Raso, M M van den Heuvel-Eibrink, S J C M M Neggers
Publikováno v:
Endocrine Connections, Vol 9, Iss 7, Pp 676-686 (2020)
Purpose: Augmented survival of childhood nephroblastoma and neuroblastoma has increased long-term side effects such as metabolic syndrome (Met S). Risk stratification is difficult after abdominal radiation because waist circumferenc e underestimate
Externí odkaz:
https://doaj.org/article/96f1d7becb514a9a8937c21704424814
Autor:
E Driehuis, N Oosterom, S G Heil, I B Muller, M Lin, S Kolders, G Jansen, R de Jonge, R Pieters, H Clevers, M M van den Heuvel-Eibrink
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0231588 (2020)
We have recently established a protocol to grow wildtype human oral mucosa organoids. These three-dimensional structures can be maintained in culture long-term, do not require immortalization, and recapitulate the multilayered composition of the epit
Externí odkaz:
https://doaj.org/article/bdaf1d17b670442ea0e22c261882a292
Autor:
E Driehuis, N Oosterom, S G Heil, I B Muller, M Lin, S Kolders, G Jansen, R de Jonge, R Pieters, H Clevers, M M van den Heuvel-Eibrink
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237488 (2020)
[This corrects the article DOI: 10.1371/journal.pone.0231588.].
Externí odkaz:
https://doaj.org/article/253e4055409342f79bf94a1683f7b06e
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0210646 (2019)
Childhood cancer patients treated with platinums often develop hearing loss and the degree is classified according to different scales globally. Our objective was to compare concordance between five well-known ototoxicity scales used for childhood ca
Externí odkaz:
https://doaj.org/article/23c096cb14d8485bb46c913e3db8b378
Autor:
J A Hol, M I Lopez-Yurda, H Van Tinteren, M Van Grotel, J Godzinski, G Vujanic, F Oldenburger, B De Camargo, G L Ramírez-Villar, C Bergeron, K Pritchard-Jones, N Graf, M M Van den Heuvel-Eibrink
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221373 (2019)
BackgroundTo enhance risk stratification for Wilms tumour (WT) in a pre-operative chemotherapy setting, we explored the prognostic significance and optimal age cutoffs in patients treated according to International Society of Paediatric Oncology Rena
Externí odkaz:
https://doaj.org/article/832b66d90e5e48309fa7573090bd810d
Autor:
Alison Leiper, L. C. M. Kremer, Jeanette Falck Winther, James M. Byrne, Dalit Modan-Moses, M M van den Heuvel-Eibrink, Riccardo Haupt, C.B. Lambalk, Melanie Kaiser, J.W.R. Twisk, M. van den Berg, Claudia Spix, Uta Dirksen, Claire Berger, Tomáš Kepák, Jarmila Kruseova, M. van Dijk, Cécile M. Ronckers, E. van Dulmen-den Broeder, Peter Kaatsch, F.E. van Leeuwen, Desiree Grabow, A.L.F. van der Kooi, Victoria Grandage, Sophie D. Fosså
Publikováno v:
PanCareLIFE Consortium 2021, ' Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors : investigating dose-effect relationships in a European case-control study (PanCareLIFE) ', Human reproduction (Oxford, England), vol. 36, no. 6, pp. 1561-1573 . https://doi.org/10.1093/humrep/deab035
Human reproduction (Oxford, England), 36(6), 1561-1573. Oxford University Press
van den Berg, M H, van Dijk, M, Byrne, J, Berger, C, Dirksen, U, Winther, J F, Fossa, S D, Grabow, D, Grandage, V L, Haupt, R, van den Heuvel-Eibrink, M M, Kaiser, M, Kepak, T, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Lambalk, C B, van Leeuwen, F E, Leiper, A, Modan-Moses, D, Spix, C, Twisk, J W R, Ronckers, C M, Kaatsch, P, van Dulmen-den Broeder, E & PanCareLIFE Consortium 2021, ' Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors : investigating dose-effect relationships in a European case-control study (PanCareLIFE) ', Human Reproduction, vol. 36, no. 6, pp. 1561-1573 . https://doi.org/10.1093/humrep/deab035
Human reproduction (Oxford, England), 36(6), 1561-1573. Oxford University Press
van den Berg, M H, van Dijk, M, Byrne, J, Berger, C, Dirksen, U, Winther, J F, Fossa, S D, Grabow, D, Grandage, V L, Haupt, R, van den Heuvel-Eibrink, M M, Kaiser, M, Kepak, T, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Lambalk, C B, van Leeuwen, F E, Leiper, A, Modan-Moses, D, Spix, C, Twisk, J W R, Ronckers, C M, Kaatsch, P, van Dulmen-den Broeder, E & PanCareLIFE Consortium 2021, ' Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors : investigating dose-effect relationships in a European case-control study (PanCareLIFE) ', Human Reproduction, vol. 36, no. 6, pp. 1561-1573 . https://doi.org/10.1093/humrep/deab035
STUDY QUESTION Which chemotherapeutic agents and body site-specific radiation fields are dose-dependently associated with an increased risk of fertility impairment in long-term female childhood, adolescent and young adulthood (CAYA) cancer survivors?
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d41e6100776ef7922e69c991967087
https://pure.eur.nl/en/publications/413cab3b-347e-42bc-9dfb-feee89874cec
https://pure.eur.nl/en/publications/413cab3b-347e-42bc-9dfb-feee89874cec
Autor:
Wim J. E. Tissing, J Kruseova, A E Hoetink, G Calaminus, R Haupt, I K Domingo, E van Dulmen-den Broeder, Amit P. Bhavsar, J Byrne, H Hasle, C Spix, S Elsner, A P Nagtegaal, L Kenborg, J Gebauer, O Zolk, S M F Pluijm, A J M Meijer, H Binder, R A Ozinga, C Rechnitzer, S J C M M Neggers, M L Garrè, P Matulat, D Deuster, T Langer, Britt I. Drögemöller, H. J. H. van der Pal, D Grabow, Leontien C. M. Kremer, Galen E.B. Wright, E Clemens, A.L.F. van der Kooi, M Kaiser, Bruce Carleton, F A Diepstraten, J F Winther, C Blattmann, L Broer, M van Grotel, R Parfitt, A G Am Zehnhoff-Dinnesen, K Kepakova, H Lackner, M M van den Heuvel-Eibrink, Shahrad Rod Rassekh, T Kepak, A. C. H. de Vries, Beth Brooks, André G. Uitterlinden, C. E. Kuehni, A Tillmanns, Wilbert P. Vermeij, Colin J. D. Ross, P Kaatsch
Publikováno v:
37. Wissenschaftliche Jahrestagung der Deutschen Gesellschaft für Phoniatrie und Pädaudiologie (DGPP); 20210917-20210918; sine loco [digital]; DOCP15 /20211028/
The PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, The PanCareLIFE consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, the PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, 64 . https://doi.org/10.1038/s41698-021-00178-z
npj Precision Oncology, 5(1):64. Springer Nature
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
NPJ Precision Oncology
NPJ precision oncology, 5(1):64, 1-8. Nature Research
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
The PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, The PanCareLIFE consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, the PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, 64 . https://doi.org/10.1038/s41698-021-00178-z
npj Precision Oncology, 5(1):64. Springer Nature
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
NPJ Precision Oncology
NPJ precision oncology, 5(1):64, 1-8. Nature Research
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Background: Ototoxicity (hearing loss, tinnitus and/or vertigo) is a serious adverse event of cisplatin treatment in children with cancer. The heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b1abb74a67b5c6ca531ead07151865
http://www.egms.de/en/meetings/dgpp2021/21dgpp30.shtml
http://www.egms.de/en/meetings/dgpp2021/21dgpp30.shtml
Autor:
F A Diepstraten, A E Hoetink, M van Grotel, A D R Huitema, R J Stokroos, M M van den Heuvel-Eibrink, A J M Meijer
Publikováno v:
JAC-Antimicrobial Resistance
BackgroundOtotoxicity has been reported after administration of aminoglycosides and glycopeptides.ObjectivesTo identify available evidence for the occurrence and determinants of aminoglycoside- and glycopeptide-related ototoxicity in children.Materia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a84c8b81a9ced845825c07e44be8b15
https://doi.org/10.1093/jacamr/dlab184
https://doi.org/10.1093/jacamr/dlab184
Autor:
Gabriele Calaminus, Katja Baust, Claire Berger, Julianne Byrne, Harald Binder, Leonie Casagranda, Desiree Grabow, Martha Grootenhuis, Peter Kaatsch, Melanie Kaiser, Tomas Kepak, Kateřina Kepáková, Leontien C M Kremer, Jarmila Kruseova, Ales Luks, Claudia Spix, Marleen van den Berg, Marry M M van den Heuvel-Eibrink, Eline van Dulmen-den Broeder, Rahel Kuonen, Grit Sommer, Claudia Kuehni
BACKGROUND Survival after childhood cancer has improved to more than 80% during the last few years, leading to an increased number of childhood cancer survivors. Cancer itself, or its treatment, may cause chronic health conditions, including somatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32c05147d8483469f1a3f86647c4bcc3
https://doi.org/10.2196/preprints.21851
https://doi.org/10.2196/preprints.21851